(Q24246197)

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Compliance with 14-day primaquine therapy for radical cure of vivax malaria--a randomized placebo-controlled trial comparing unsupervised with supervised treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Randomized controlled trials of 5- and 14-days primaquine therapy against relapses of vivax malaria in an Afghan refugee settlement in Pakistan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (western Amazon region, Brazil) to regimens including chloroquine and primaquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Primaquine for prevention of malaria in travelers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

High dose of primaquine in primaquine resistant vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

A 5 days primaquine regimen as anti-relapse therapy for Plasmodium vivax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Chloroquine sensitivity of Plasmodium vivax in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Treatment of vivax malaria on the western border of Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Clinical efficacy of chloroquine followed by primaquine for Plasmodium vivax treatment in Azerbaijan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Primaquine therapy for malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

The hypnozoite and relapse in primate malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Molecular analysis of strains of Plasmodium vivax from paired primary and relapse infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

A metropolitan hospital in a non-endemic area provides a sampling pool for epidemiological studies on vivax malaria in Sri Lanka

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Interventions for enhancing medication adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Systematic reviews in health care: Assessing the quality of controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Safety and tolerability of elubaquine (bulaquine, CDRI 80/53) for treatment of Plasmidium vivax malaria in Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

Drugs for treating uncomplicated malaria in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

Plasmodium vivax polymorphism in a clinical drug trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

Assessment of the response to reduced treatment schemes for vivax malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

Clinical efficacy of four schemes for vivax malaria treatment in children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

Primaquine resistance in Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

Short report: a consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

The neglected burden of Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004389.PUB2

7 January 2021

10.1002/14651858.CD004389.PUB2

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

PubMed publication ID

17253504

1 reference

Consolidated OpenCitations Corpus – April 2017